Literature DB >> 20599804

American ginseng: potential structure-function relationship in cancer chemoprevention.

Lian-Wen Qi1, Chong-Zhi Wang, Chun-Su Yuan.   

Abstract

Ginseng has a prominent position on the list of best-selling herbal products in the world, and its main active constituents are thought to be ginsenosides. Compared with the long history of use and widespread research on Asian ginseng, studies of American ginseng are relatively limited, especially regarding cancer chemoprevention. In recent studies of American ginseng, steaming or heating altered the ginsenoside profile and thereby increased anticancer effects. Yet the ginsenoside structures and their activities have not been systematically elucidated. In this commentary, we introduce the different ginsenosides in American ginseng, both the naturally occurring compounds and those resulting from steaming or biotransformation. We briefly review American ginseng's reported anticancer effects and their mechanisms of action, and explore the possible structural-function relationship with a focus on sugar molecules, hydroxyl groups and stereoselectivity in ginsenosides. Understanding these relationships may produce insights into chemical and pharmacological approaches for enhancing the chemopreventive effects of ginsenoside and for developing novel anticancer agents. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599804     DOI: 10.1016/j.bcp.2010.06.023

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  85 in total

Review 1.  Role of phytochemicals in colorectal cancer prevention.

Authors:  Yu-Hua Li; Yin-Bo Niu; Yang Sun; Feng Zhang; Chang-Xu Liu; Lei Fan; Qi-Bing Mei
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

2.  Anti-proliferative effects of ginsenosides extracted from mountain ginseng on lung cancer.

Authors:  Dong Gyu Lee; Sung-Il Jang; Young-Rang Kim; Kyeong Eun Yang; So Jung Yoon; Zee-Won Lee; Hyun Joo An; Ik-Soon Jang; Jong-Soon Choi; Hwa-Seung Yoo
Journal:  Chin J Integr Med       Date:  2014-08-26       Impact factor: 1.978

3.  Ginsenoside Re: Its chemistry, metabolism and pharmacokinetics.

Authors:  Dacheng Peng; Huashan Wang; Chenling Qu; Laihua Xie; Sheila M Wicks; Jingtian Xie
Journal:  Chin Med       Date:  2012-02-07       Impact factor: 5.455

4.  Use of complementary therapies for cancer symptom management: results of the 2007 National Health Interview Survey.

Authors:  Joel G Anderson; Ann Gill Taylor
Journal:  J Altern Complement Med       Date:  2012-03       Impact factor: 2.579

5.  Caspase-mediated pro-apoptotic interaction of panaxadiol and irinotecan in human colorectal cancer cells.

Authors:  Guang-Jian Du; Chong-Zhi Wang; Zhi-Yu Zhang; Xiao-Dong Wen; Jacqueline Somogyi; Tyler Calway; Tong-Chuan He; Wei Du; Chun-Su Yuan
Journal:  J Pharm Pharmacol       Date:  2012-02-21       Impact factor: 3.765

Review 6.  Metabolism of ginseng and its interactions with drugs.

Authors:  Lian-Wen Qi; Chong-Zhi Wang; Guang-Jian Du; Zhi-Yu Zhang; Tyler Calway; Chun-Su Yuan
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

7.  Establishment of specific cytotoxic T lymphocyte culture system and its inhibitory effect on ovarian cancer.

Authors:  Mingxing Sui; Lihui Si; Tianmin Xu; Manhua Cui
Journal:  Oncol Lett       Date:  2016-09-28       Impact factor: 2.967

8.  Red notoginseng: higher ginsenoside content and stronger anticancer potential than Asian and American ginseng.

Authors:  Shi Sun; Lian-Wen Qi; Guang-Jian Du; Sangeeta R Mehendale; Chong-Zhi Wang; Chun-Su Yuan
Journal:  Food Chem       Date:  2011-04-15       Impact factor: 7.514

9.  Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing.

Authors:  Tao Niu; Diane L Smith; Zhen Yang; Song Gao; Taijun Yin; Zhi-Hong Jiang; Ming You; Richard A Gibbs; Joseph F Petrosino; Ming Hu
Journal:  Pharm Res       Date:  2012-12-20       Impact factor: 4.200

10.  20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor.

Authors:  Bo Cao; Xichun Liu; Jing Li; Shuang Liu; Yanfeng Qi; Zhenggang Xiong; Allen Zhang; Thomas Wiese; Xueqi Fu; Jingkai Gu; Paul S Rennie; Oliver Sartor; Benjamin R Lee; Clement Ip; Lijuan Zhao; Haitao Zhang; Yan Dong
Journal:  Int J Cancer       Date:  2012-08-20       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.